Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention
Article first published online: 2 MAY 2013
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Molecular Nutrition & Food Research
Special Issue: Cocoa and Human Health
Volume 57, Issue 6, pages 962–973, June 2013
How to Cite
Llorach, R., Urpi-Sarda, M., Tulipani, S., Garcia-Aloy, M., Monagas, M. and Andres-Lacueva, C. (2013), Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention. Mol. Nutr. Food Res., 57: 962–973. doi: 10.1002/mnfr.201200736
- Issue published online: 7 JUN 2013
- Article first published online: 2 MAY 2013
- Manuscript Accepted: 15 MAR 2013
- Manuscript Revised: 1 MAR 2013
- Manuscript Received: 5 NOV 2012
- CICYT. Grant Numbers: AGL2009–13906-C02–01, AGL2010–10084-E
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Figure S1. Mass spectra of (A) tyrosine-O-sulfate (m/z 262.0359), (B) butyrylcarnitine (m/z 232.1547) and (C) methylglutarylcarnitine (m/z 290.1600).
Table S1. Summary of parameters for assessing OPLS-DA modeling quality after removing five volunteers (ten samples for each model) in each OPLS-DA model. This procedure has been repeated four times using different samples each time.
Table S2. The misclassification table for the OPLS-DA models. Each subtable corresponds to each of the four rounds. b: basal, c:cocoa and m:milk.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.